Indefinite Delivery Contract SPE2DR25D6905

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, valued at $999,999,999, runs through December 2036 and covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The purpose of this acquisition is for DLA Troop Support to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), which provides worldwide support to the Defense Health Agency (DHA), Department of Defense (DoD) customers, the United States Coast Guard, Designated Providers, Other Government Agencies, and the US Naval Fleet. This IDC serves as a primary vehicle for efficient government procurement of essential pharmaceutical and medical supplies, enabling DLA to diversify its supplier base and increase the Department of Defense's resiliency and access to vital pharmaceuticals during times of contingency or natural disasters.